0001209191-15-050701.txt : 20150605
0001209191-15-050701.hdr.sgml : 20150605
20150605172520
ACCESSION NUMBER: 0001209191-15-050701
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150603
FILED AS OF DATE: 20150605
DATE AS OF CHANGE: 20150605
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZS Pharma, Inc.
CENTRAL INDEX KEY: 0001459266
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263305698
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 508 WRANGLER DRIVE, SUITE 100
CITY: COPPELL
STATE: TX
ZIP: 75019
BUSINESS PHONE: 650-458-4100
MAIL ADDRESS:
STREET 1: 508 WRANGLER DRIVE, SUITE 100
CITY: COPPELL
STATE: TX
ZIP: 75019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NOHRA GUY P
CENTRAL INDEX KEY: 0001198330
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36489
FILM NUMBER: 15916800
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JANNEY DANIEL
CENTRAL INDEX KEY: 0001198325
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36489
FILM NUMBER: 15916801
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHAMPSI FARAH
CENTRAL INDEX KEY: 0001198321
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36489
FILM NUMBER: 15916802
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alta Partners Management VIII, LLC
CENTRAL INDEX KEY: 0001399894
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36489
FILM NUMBER: 15916803
BUSINESS ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-362-4022
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alta Partners VIII, L.P.
CENTRAL INDEX KEY: 0001399763
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36489
FILM NUMBER: 15916804
BUSINESS ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-362-4022
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-06-03
0
0001459266
ZS Pharma, Inc.
ZSPH
0001399763
Alta Partners VIII, L.P.
ONE EMBARCADERO CENTER, SUITE 3700
SAN FRANCISCO
CA
94111
0
0
1
0
0001399894
Alta Partners Management VIII, LLC
ONE EMBARCADERO CENTER, SUITE 3700
SAN FRANCISCO
CA
94111
0
0
1
0
0001198321
CHAMPSI FARAH
ONE EMBARCADERO CENTER, SUITE 3700
SAN FRANCISCO
CA
94111
0
0
1
0
0001198325
JANNEY DANIEL
ONE EMBARCADERO CENTER, SUITE 3700
SAN FRANCISCO
CA
94111
0
0
1
0
0001198330
NOHRA GUY P
ONE EMBARCADERO CENTER, SUITE 3700
SAN FRANCISCO
CA
94111
1
0
1
0
Common Stock
2015-06-03
4
S
0
23189
56.60
D
2910478
D
Common Stock
2015-06-04
4
S
0
39495
57.21
D
2870983
D
Common Stock
2015-06-04
4
S
0
48913
57.71
D
2822070
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $56.50 - $56.76, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
These shares were sold by Alta Partners VIII, L.P. ("APVIII"), the holder of record of the securities. Alta Partners Management VIII, LLC ("APMVIII") is the general partner of APVIII. Guy Nohra, Daniel Janney and Farah Champsi are managing directors of APMVIII and exercise shared voting and investment power with respect to the shares owned by APVIII. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein. Mr. Nohra is also a director of the issuer.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $56.50 - $57.50, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $57.51 - $58.00, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.
/s/Laurence Randall, Chief Financial Officer
2015-06-05
Laurence Randall, Chief Financial Officer
2015-06-05
Farah Champsi
2015-06-05
Daniel Janney
2015-06-05
Guy Nohra
2015-06-05